Success Metrics

Clinical Success Rate
94.4%

Based on 17 completed trials

Completion Rate
94%(17/18)
Active Trials
2(9%)
Results Posted
35%(6 trials)
Terminated
1(5%)

Phase Distribution

Ph not_applicable
3
14%
Ph phase_1
3
14%
Ph phase_2
4
18%
Ph phase_3
7
32%
Ph early_phase_1
1
5%
Ph phase_4
4
18%

Phase Distribution

4

Early Stage

4

Mid Stage

11

Late Stage

Phase Distribution22 total trials
Early Phase 1First-in-human
1(4.5%)
Phase 1Safety & dosage
3(13.6%)
Phase 2Efficacy & side effects
4(18.2%)
Phase 3Large-scale testing
7(31.8%)
Phase 4Post-market surveillance
4(18.2%)
N/ANon-phased studies
3(13.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.4%

17 of 18 finished

Non-Completion Rate

5.6%

1 ended early

Currently Active

2

trials recruiting

Total Trials

22

all time

Status Distribution
Active(2)
Completed(17)
Terminated(1)
Other(2)

Detailed Status

Completed17
Recruiting2
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
2
Success Rate
94.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (4.5%)
Phase 13 (13.6%)
Phase 24 (18.2%)
Phase 37 (31.8%)
Phase 44 (18.2%)
N/A3 (13.6%)

Trials by Status

completed1777%
terminated15%
recruiting29%
unknown29%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT06904274Phase 3

Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months

Recruiting
NCT05255653Phase 2

Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features

Recruiting
NCT02228681Phase 2

Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

Completed
NCT00830414Phase 1

Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women

Completed
NCT03675139Phase 3

MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

Completed
NCT03018249Early Phase 1

Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

Completed
NCT04654741Phase 4

The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles

Unknown
NCT02103764Phase 3

Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB

Unknown
NCT02272647Phase 1

Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women

Completed
NCT02872818Phase 4

Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia

Completed
NCT02340013Phase 4

Endometrial Shedding Prior to Ovulation Induction Pilot Study

Completed
NCT01011751Phase 3

Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma

Completed
NCT00044837Phase 1

Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women

Terminated
NCT01148420Phase 4

DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding

Completed
NCT00360490Phase 3

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

Completed
NCT01143207Not Applicable

PK of Depo SubQ Injected in the Upper Arm

Completed
NCT01472315Phase 2

Postmenopausal Women,Treatment of Sleep Apnea and Co-morbidities

Completed
NCT00016601Not Applicable

Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women

Completed
NCT00191113Phase 3

Somatropin Treatment to Final Height in Turner Syndrome

Completed
NCT00006324Not Applicable

Hormonal Birth Control and the Risk of Acquiring HIV

Completed

Drug Details

Intervention Type
DRUG
Total Trials
22